Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice

Diabetes

Volumn 47, Issue 7, 1998, Pages 1046-1052

  Pederson, Raymond A ^a   Satkunarajah, Malathy ^b   McIntosh, Christopher H S ^a   Scrocchi, Louise A ^b   Flamez, Daisy ^c   Schult, Frans ^c   Drucker, Daniel J ^b   Wheeler, Michael B ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c DIABETES RESEARCH CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RECEPTOR BINDING; FOOD INTAKE; GLUCOSE TOLERANCE; GLYCOGEN SYNTHESIS; HORMONE ACTION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALS; BLOOD GLUCOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCOSE TOLERANCE TEST; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, MUTANT STRAINS; PANCREAS; PANCREATIC HORMONES; PROINSULIN; RECEPTORS, GLUCAGON; RNA, MESSENGER;

EID: 0031747107     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.7.1046     Document Type: Article

References (50)

1. Unger RH, Eisentraut AM: Entero-insular axis. Arch Intern Med 123:261-266, 1969
2. Pederson RA: GIP. In Gut Peptides. Walsh J, Dockray G, Eds. New York, Raven, 1993, p. 217-259
3. Habener JF: The incretin concept and its relevance to diabetes. Endocrinol Metab Clin North Am 22:775-794, 1993
4. Holst JJ: Enteroglucagon. Annu Rev Physiol 59:257-291, 1997
5. Drucker DJ, Philippe J, Mojsov S, Chick WL, Habener JF: Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc Natl Acad Sci USA 84:3434-3438, 1987
6. Fehmann H-C, Goke B: Characterization of GIP(1-30) and GIP(1-42) as stimulators of proinsulin gene transcription. Peptides 16:1149-1152, 1995
7. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ: Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38:665-673, 1993
8. Willms B, Werner J, Holst JJ, Orskov C, Creutzfeldt W, Nauck MA: Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36)amide in type 2 (non-insulin dependent) diabetic patients. J Clin Endocrinol Metab 81:327-332, 1996
9. Kawai K, Suzuki S, Ohashi S, Mukai H, Ohmori H, Murayama Y, Yamashita K: Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. Endocrinology 124:1768-1773, 1989
10. Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S: Glucagonostatic and insulinotropic action of glucagon-like peptide I-(7-36)-amide. Diabetes 38:902-905, 1989
11. Nauck M, Stockmann F, Ebert R, Creutzfeldt W: Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46-52, 1986
12. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W: Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307, 1993
13. Wang Z, Wang RM, Owji AA, Smith DM, Ghatei MA, Bloom SR: Glucagon-like peptide 1 is a physiological incretin in rat. J Clin Invest 95:417-421, 1995
14. Kolligs F, Fehmann H-C, Göke R, Göke B: Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19, 1995
15. Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM: Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP): effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98:2440-2445, 1996
16. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ: Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide receptor gene. Nature Med 2:1254-1258, 1996
17. Pederson RA, Buchan AMJ, Zahedi-Asl S, Chan CB, Brown JC: Effect of jejunoileal bypass in the rat on the enteroinsular axis. Regul Pept 5:53-63, 1982
18. Van Schravendijk CFH, Kiekens R, Pipeleers DG: Pancreatic b cell heterogeneity in glucose-induced insulin secretion. J Biol Chem 267:21344-21348, 1992
19. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Chem 72:248-254, 1976
20. Morgan LM, Morris BA, Marks V: Radioimmunoassay of gastric inhibitory polypeptide. Ann Clin Biochem 15:172-177, 1978
21. 6-14) and quantification of glucose-induced increases in GIP mRNAs. Biochim Biophys Acta 1308:111-113, 1996
22. Brubaker PL, Drucker DJ, Greenberg GR: Synthesis and secretion of somatostatin-28 by fetal rat intestinal cells in culture. Am J Physiol 258:G974-G981, 1990
23. Brubaker PL, Greenberg GR: Calcitonin gene-related peptide-1 preferentially stimulates secretion of somatostatin from intestinal cell cultures. Endocrinology 133:2833-2837, 1993
24. Greenberg GR: Influence of vagal integrity on gastrin and somatostatin release in dogs. Gastroenterology 93:994-1001, 1993
25. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Chem 162:156-159, 1987
26. Drucker DJ, Brubaker PL: Proglucagon gene expression is regulated by a cyclic AMP-dependent pathway in rat intestine. Proc Natl Acad Sci U S A 86:3953-3957, 1989
27. Fehmann H-C, Habener JF: Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130:159-166, 1992
28. Wang Y, Perfetti R, Greig NH, Holloway HW, DeOre KA, Montrose-Raflzadeh C, Elahi D, Egan JM: Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats. J Clin Invest 99:2883-2889, 1997
29. Yamato E, Noma Y, Tahara Y, Ikegami H, Yamamoto Y, Cha T, Yoneda H, Ogihara T, Ohboshi C, Hirota M, Shima K: Suppression of synthesis and release of glucagon by glucagon-like peptide-1 (7-36 amide) without affect on mRNA level in isolated rat islets. Biochem Biophys Res Commun 167:431-437, 1990
30. Thorens B: Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 89:8641-8645, 1992
31. Wheeler MB, Lu M, Dillon JS, Leng X-H, Chen C, Boyd AE III: Functional expression of the rat glucagon-like peptide-I receptor evidence for coupling to both adenyl cyclase and phospholipase-C. Endocrinology 133:57-62, 1993
32. Campos RV, Lee YC, Drucker DJ: Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134:2156-2164, 1994
33. Wei Y, Mojsov S: Tissue-specific expression of the human receptor for glucagon-like peptide 1: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett 358:219-224, 1995
34. Bullock BP, Heller RS, Habener JF: Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide 1 receptor. Endocrinology 137:2968-2978, 1996
35. Morales M, Lopez-Delgado MI, Alcantara A, Luque MA, Clemente F, Marquez L, Puente J, Vinambres C, Malaisse WJ, Villanueva-Penacarrillo ML, Valverde I: Preserved GLP-1 effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats. Diabetes 46:1264-1269, 1997
36. Scrocchi LA, Marshall BA, Cook SM, Brubaker PL, Drucker DJ: Glucose homeostasis in mice with disruption of GLP-1 receptor signaling. Diabetes 47:632-639, 1998
37. Brubaker PL: Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128:3175-3182, 1991
38. Dumoulin V, Dakka T, Plaisancie P, Chayvialle J-A, Cuber J-C: Regulation of glucagon-like peptide-1 (7-36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum. Endocrinology 136:5182-5188, 1995
39. Roberge JN, Brubaker PL: Regulation of intestinal proglucagon-derivod peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240, 1993
40. Bryer-Ash M, Cheung A, Pederson RA: Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats. Regul Pept 51:101-109, 1994
41. Sirinek KR, Pace WG, Crockett SE, O'Dorisio TM, Mazzaferri EI, Cataland S: Insulin-induced attenuation of glucose-stimulated gastric inhibitory polypeptide secretion. Am J Surg 135:151-155, 1978
42. Ebert R, Frerichs H, Creutzfeldt W: Impaired feedback control of fat induced gastric inhibitory polypoptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest 9:129-135, 1979
43. Schirra J, Katschinski M, Weidmann C, Schafer T, Wank U, Arnold R, Goke B: Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97:92-103, 1996
44. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F: Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45:257-261, 1996
45. Samols E, Marri G, Marks V: Interrelationship of glucagon, insulin, and glucose: the insulinogenic effect of glucagon. Diabetes 15:855-865, 1966
46. Pipeleers D, in't Veld P, Maes E, Van De Winkel M: Glucose-induced insulin release depends on functional cooperation between islet cells. J Invest Dermatol 98:198-203, 1992
47. Kofod H, Adelhorst K, Christensen LB, Fuglondorf J, Godtfredsen SE, Kirk O, Lundgren K: Beta cells do not have, glucagon receptors but GLP-1 receptors. Digestion 54:346-347, 1993
48. Kieffer TJ, Heller RS, Unson CG, Weir GC, Habener JF: Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets. Endocrinology 137:5119-5125, 1996
49. Gerber PP, Trimble ER, Wollheim CB, Renold AE: Effect of insulin on glucose- and arginine-stimulated somatostatin secretion from the isolated perfused rat pancreas. Endocrinology 109:279-283, 1981
50. Szecowka J, Grill V, Sandberg E, Efendic S: Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. Acta Endocrinol (Copenh) 99:416-421, 1982